A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2009
12/30/2009	EP2137150A1 Piperidinones useful in the treatment of inflammation
12/30/2009	EP2137141A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
12/30/2009	EP2057148B1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
12/30/2009	EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
12/30/2009	EP1848714B1 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
12/30/2009	EP1805202B1 Conjugates with anti-inflammatory activity
12/30/2009	EP1664027B1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
12/30/2009	EP1523541B1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
12/30/2009	EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/30/2009	EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis
12/30/2009	EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof
12/30/2009	CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/30/2009	CN101612402A Interferon antagonist and use of Flt3L interferon
12/30/2009	CN100575482C Novel cytokine zcytor17 ligand
12/30/2009	CN100575358C Honeysuckle extract and its preparation method and application
12/30/2009	CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009	CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/30/2009	CN100574797C Plaster for treating osteopathy
12/30/2009	CN100574791C Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease
12/30/2009	CN100574788C Oral Chinese traditional medicine composition for treating atrophic arthritis
12/30/2009	CN100574783C Medicine for relieving inflammation and pain
12/30/2009	CN100574780C Compositions against inflammatory processes
12/30/2009	CN100574753C Medicinal salt with local narcosis and antiphlogosis activity and its preparation process
12/30/2009	CN100574747C Pediatric paracetamol gelatin preparation for children and its preparing method
12/30/2009	CA2729217A1 6-substituted phenoxychroman carboxylic acid derivatives
12/30/2009	CA2727455A1 Heteroaryl compounds and uses thereof
12/29/2009	US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/29/2009	US7638623 Galactoside inhibitors of galectins
12/29/2009	US7638607 Urocortin proteins and uses thereof
12/29/2009	US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
12/29/2009	US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009	US7638546 Imidazolyl derivatives
12/29/2009	US7638540 Benzofuran compound and medicinal composition containing the same
12/29/2009	US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders
12/29/2009	US7638534 Use of indazole derivatives for the treatment of neuropathic pain
12/29/2009	US7638520 Pyrimidine compounds
12/29/2009	US7638494 G-type peptides to ameliorate atherosclerosis
12/29/2009	US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
12/29/2009	US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
12/29/2009	US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009	US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
12/29/2009	US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine
12/29/2009	CA2524043C 1-(2h-pyrazol-3-yl)-3-{4-'1-(benzoyl)-piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/29/2009	CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/29/2009	CA2451932C Pyrrolopyrimidines as protein kinase inhibitors
12/29/2009	CA2447521C Delivery of antihistamines through an inhalation route
12/29/2009	CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/29/2009	CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists
12/29/2009	CA2415683C Indoloquinazolinones
12/29/2009	CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels
12/29/2009	CA2287214C Substituted benzopyran derivatives for the treatment of inflammation
12/29/2009	CA2264802C Antioxidant derived from lentil and its preparation and uses
12/24/2009	US20090318562 Use of Bupropion Metabolites for the Treatment of Inflammatory Disorders
12/24/2009	US20090318558 Solvent system of hardly soluble drug with improved dissolution rate
12/24/2009	US20090318551 Uses of analogs of 3-o-acetyl-11-keto-beta-boswellic acid
12/24/2009	US20090318524 Bicyclic tetrahydropyrrole compounds
12/24/2009	US20090318523 Benzoisoindole derivatives and their use as ep4 receptor agonists
12/24/2009	US20090318498 Piperidyl acrylamide antagonists of ccr2
12/24/2009	US20090318494 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
12/24/2009	US20090318463 Indolylmaleimide Derivatives
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318442 Thiazolyl-and oxazolyl-isoquinolinones and methods for using them
12/24/2009	US20090318425 Apoptosis signal-regulating kinase 1 inhibitors
12/24/2009	US20090318407 Inhibitors of protein kinases
12/24/2009	US20090318364 Method and peptide for regulating cellular activity
12/24/2009	US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
12/24/2009	US20090318342 Compounds
12/24/2009	US20090318341 Methods of using OSK1 peptide analogs
12/24/2009	US20090317495 Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases
12/24/2009	US20090317494 Herbal composition containing COX-2 and its manufacturing method
12/24/2009	US20090317479 Nanoparticles containing water-soluble non-peptide low-molecular weight drug
12/24/2009	US20090317440 Anti-mitotic anti-proliferative compounds
12/24/2009	US20090317405 Antibody and uses thereof
12/24/2009	US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology
12/24/2009	US20090317389 Fusion molecules and methods for treatment of immune diseases
12/23/2009	WO2009155497A1 Product and composition for alleviating post-menstrual symptoms comprising carapa procera and calotropis procera
12/23/2009	WO2009155389A1 Triazolopyridine compounds useful as kinase inhibitors
12/23/2009	WO2009155388A1 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
12/23/2009	WO2009155116A2 Methods of reducing pain and inflammation
12/23/2009	WO2009154944A2 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
12/23/2009	WO2009154785A2 C4-substituted alpha-keto oxazoles
12/23/2009	WO2009154741A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors
12/23/2009	WO2009154737A1 Boronate ester compounds and pharmaceutical compositions thereof
12/23/2009	WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
12/23/2009	WO2009154148A1 Analgesic anti-inflammatory preparation for external application
12/23/2009	WO2009154147A1 Oxybuprocaine-containing analgesic/antipruritic preparation for external application
12/23/2009	WO2009153514A1 Phenyl-alkyl piperazines having a modulating activity of tnf
12/23/2009	WO2009152724A1 Use of paederosidic acid methyl ester in manufacture of medicaments for treating pain and/or inflammation.
12/23/2009	WO2009129511A3 Fluocinolone formulations in a biodegradable polymer carrier
12/23/2009	WO2009129408A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/23/2009	WO2009114139A3 Methods, compositions, and kits for treating pain and pruritis
12/23/2009	WO2009087005A3 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
12/23/2009	WO2009020534A3 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines
12/23/2009	WO2008155140A8 Alkynylpyrimidines as tie2 kinase inhibitors
12/23/2009	WO2008142550A8 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
12/23/2009	EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy
12/23/2009	EP2135605A2 Therapeutic delivery of carbon monoxide
12/23/2009	EP2134686A1 Piperidinones useful in the treatment of inflammation
12/23/2009	EP1874778B1 Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
12/23/2009	EP1549651B1 Pyrimidopyrimidones as kinase inhibitors

1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 1272